Parkinson's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Parkinson's Disease, including details on symptoms, treatment, genetics, medication.

Volume 5 (2008), Issue 3 (March)

1. Treatment options for non-motor symptoms in late-stage Parkinson's disease.
   Expert Opin Pharmacother, 9(4): 523-35. [Abstract] [Full-text]
2. Neurodegeneration and motor dysfunction in a conditional model of Parkinson's disease.
   J Neurosci, 28(10): 2471-84. [Abstract] [Full-text]
3. Natural history and effectiveness of early detection of Parkinson's disease: results from two community-based programmes in Taiwan (KCIS no. 11).
   J Eval Clin Pract, 14(2): 198-202. [Abstract] [Full-text]
4. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
   Acta Neurol Scand, 117(4): 255-9. [Abstract] [Full-text]
5. A case report on fixation instability in Parkinson's disease with bilateral deep brain stimulation implants.
   J Neurol Neurosurg Psychiatry, 79(4): 443-7. [Abstract] [Full-text]
6. Parkinson's disease: clinical features and diagnosis.
   J Neurol Neurosurg Psychiatry, 79(4): 368-76. [Abstract] [Full-text]
7. Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson's disease over time.
   J Neurol Neurosurg Psychiatry, 79(4): 387-91. [Abstract] [Full-text]
8. PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum.
   Hum Mutat, 29(4): 565. [Abstract] [Full-text]
9. A simple and cost-effective method of fixation of deep brain stimulation (DBS) electrode.
   Acta Neurochir (Wien), 150(4): 387-9. [Abstract] [Full-text]
10. Comprehensive analysis of LRRK2 in publicly available Parkinson's disease cases and neurologically normal controls.
    Hum Mutat, 29(4): 485-90. [Abstract] [Full-text]
11. CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases.
    Am J Clin Pathol, 129(4): 526-9. [Abstract] [Full-text]
12. Neurotrophic factors as a therapeutic target for Parkinson's disease.
    Expert Opin Ther Targets, 12(4): 437-47. [Abstract] [Full-text]
13. Potential therapeutic targets for Parkinson's disease.
    Expert Opin Ther Targets, 12(4): 425-36. [Abstract] [Full-text]
14. Exploring gene-environment interactions in Parkinson's disease.
    Hum Genet, 123(3): 257-65. [Abstract] [Full-text]
15. Patterns of bidirectional communication between cortex and basal ganglia during movement in patients with Parkinson disease.
    J Neurosci, 28(12): 3008-16. [Abstract] [Full-text]
16. Kinematic evaluation of gestural and repetitive single joint movements of the arm after posteroventral pallidotomy, subthalamotomy or both procedures combined in two Parkinson's disease patients: two case studies.
    Eur J Neurol, 15(4): 406-12. [Abstract] [Full-text]
17. Inflammation-related genes and the risk of Parkinson's disease: a multilocus approach.
    Eur J Neurol, 15(4): 431-3. [Abstract] [Full-text]
18. Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort.
    Neurology, 70(13): 1042-8. [Abstract] [Full-text]
19. Dementia and survival in Parkinson disease: a 12-year population study.
    Neurology, 70(13): 1017-22. [Abstract] [Full-text]
20. Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1).
    J Neurochem, 105(1): 18-33. [Abstract] [Full-text]
21. Characterization of fibrillation process of alpha-synuclein at the initial stage.
    Biochem Biophys Res Commun, 369(3): 910-4. [Abstract] [Full-text]
22. Diet, urate, and Parkinson's disease risk in men.
    Am J Epidemiol, 167(7): 831-8. [Abstract] [Full-text]

© 2004-2008 Parkinson's Disease Research Today. All Rights Reserved.